About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

ChIP-Seq (H3K36me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, as part of the International Human Epigenome Consortium.

ChIP-Seq (H3K36me3) assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00000586049 bam 4.7 GB Report
EGAF00000586056 bam 8.2 GB Report
EGAF00000586063 bam 5.3 GB Report
EGAF00000586070 bam 5.8 GB Report
EGAF00000586077 bam 4.7 GB Report
EGAF00000586084 bam 6.0 GB Report
EGAF00000586091 bam 4.7 GB Report
EGAF00000586098 bam 8.4 GB Report
EGAF00000586105 bam 5.9 GB Report
EGAF00000586112 bam 8.7 GB Report
EGAF00000732988 bam 6.3 GB Report
EGAF00000732990 bam 6.5 GB Report
EGAF00000733041 bam 5.9 GB Report
EGAF00000733054 bam 6.1 GB Report
EGAF00000733062 bam 3.7 GB Report
EGAF00000835463 bam 6.9 GB Report
EGAF00000835476 bam 8.4 GB Report
EGAF00000835489 bam 7.9 GB Report
EGAF00000861594 bam 6.2 GB Report
EGAF00000861595 bam 11.0 GB Report
EGAF00000864343 bam 8.1 GB Report
EGAF00000864346 bam 4.1 GB Report
EGAF00000864354 bam 6.2 GB Report
EGAF00000864356 bam 4.5 GB Report
EGAF00000864357 bam 5.7 GB Report
EGAF00000864373 bam 5.2 GB Report
EGAF00000864382 bam 5.2 GB Report
EGAF00000864391 bam 5.0 GB Report
EGAF00000864399 bam 4.0 GB Report
EGAF00000864403 bam 4.0 GB Report
EGAF00000887882 bam 11.2 GB Report
EGAF00000887886 bam 11.5 GB Report
EGAF00000887890 bam 7.9 GB Report
EGAF00000887899 bam 9.3 GB Report
EGAF00000887902 bam 8.4 GB Report
EGAF00000887906 bam 13.7 GB Report
EGAF00000887914 bam 7.3 GB Report
EGAF00000887917 bam 6.6 GB Report
EGAF00000887920 bam 8.7 GB Report
EGAF00000887923 bam 5.7 GB Report
EGAF00000887931 bam 6.7 GB Report
EGAF00000887932 bam 5.3 GB Report
EGAF00000887941 bam 7.7 GB Report
EGAF00000887949 bam 8.3 GB Report
EGAF00000887956 bam 7.6 GB Report
EGAF00000887963 bam 9.1 GB Report
EGAF00000887974 bam 7.3 GB Report
EGAF00000888675 bam 4.4 GB Report
48 Files (330.1 GB)